Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
Stock Information for Datametrex AI Limited
Loading
Please wait while we load your information from QuoteMedia.